IndiaInfoline » Markets » GLENMARK

Glenmark Pharmaceuticals Ltd - Share Price

GLENMARK

Open

523.20

Prev. Close

523.20

Turnover (lac.)

2,777

Day's High

533.00

Day's Low

518.20

52 Week's High

711.90

52 Week's Low

518.20

Book Value

426

Face Value

1

Mkt Cap (Cr.)

14,836

P/E

11.01

EPS

47.83

Divi. Yield

0.38

Financials

Switch to
Consolidated
Standalone

Loading ...

News & Updates

Peer Comparison

Name LTP PE Mar Cap NP Qtr Div. Yld Sales Qtr BV
Sun Pharmaceuticals Industries Ltd392.5546.3894,137.911,068.060.702,257.8095.21
Cipla Ltd555.6023.7244,791.20634.070.543,276.07195.87
Dr Reddys Laboratories Ltd2,565.1533.3242,564.36202.800.782,634.70763.80
Piramal Enterprises Ltd2,072.75116.0741,130.42-62.201.261,012.611,176.39
Divis Laboratories Ltd1,522.3030.4240,534.40289.351.051,256.43262.68

Figures of Market Capital(Mar Cap), Quaterly Net Profit(NP Qtr) and Quaterly Sales(Sales Qtr) are in Cr.

sentifi.com

Indiainfoline Sentifi Top 10 Most Talked About Stocks

Summary & Reports

Glenmark Pharmaceuticals Ltd is a research-driven, global, integrated pharmaceutical company. The company is a leading player in the discovery of new molecules both NCEs (new chemical entity) and NBEs (new biological entity). The company has several molecules in various stages of pre-clinical and clinical development primarily focused in the areas of Oncology, Respiratory and Dermatology. Its branded generics business has a significant... More

Registered Office

B/2 Mahalaxmi Chambers,22 Bhulabhai Desai Road,Mumbai, Maharashtra,400026

Tell. : +91-22-40189999
Website : http://www.glenmarkpharma.com
Email : complianceofficer@glenmarkpharma.com

Registrar Office

Karvy Selenium Tow-B, Nanakramguda, Hyderabad-500032 INDIA

Tell. : +91-40-67161500
Website : www.karvyfintech.com
Email : einward.ris@karvy.com

Latest Release by glenmark-pharmaceuticals-ltd

View

- <

Reco. Price

Jun 11,2019 12:23 PM

Target Price

Target Returns:

0.00%

Result Express

Glenmark Pharmaceuticals Ltd's Q2FY19 consolidated net profit rises 15.27% yoy to Rs246.82cr : Beats Estimates

Jun 17, 2019 12:49 AM

The company’s consolidated revenue stood at Rs2,581.33cr, up 14.39% yoy and 19.2% qoq.

Shareholding Snapshot

Loading ...

Corporate Action

  • Purpose

    Board Meeting

    Exp. Date

    29 May 2019

    Annc. Date

    14 May 2019

    GLENMARK PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Comp... More

  • Purpose

    Board Meeting

    Exp. Date

    14 Feb 2019

    Annc. Date

    01 Feb 2019

    GLENMARK PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Comp... More